News & Announcements
UMB News: Face to Face: A New Approach to Fighting COVID-19
June 16, 2020
It’s an understatement, of course, to say that the worldwide mobilization of scientific resources to find a vaccine against SARS-CoV-2 — the virus that causes the disease COVID-19 — is unprecedented. As many as 160 vaccine candidates are under examination, with at least 10 already in human trials. On Wednesday, it was reported that the National Institutes of Health will fund the phase 3 trials of three of those starting this summer, the candidates of Moderna Therapeutics, Oxford University/AstraZeneca, and Johnson & Johnson.
But while the world waits for that silver bullet to end the COVID-19 pandemic, interest is surging in the scientific community for a re-examination of a decades-old vaccine for a different disease. Two esteemed scientists from the Institute of Human Virology (IHV) in the University of Maryland School of Medicine presented that case in the Journal Science on Thursday.
Read the full story from UMB.